Twitxy Saved

Joe

Verified account This account is verified. Learn more

@Gantosj

Equity market consultant. Technical Analysis Trader with over 25 years of experience. #Biotech Deep dive research.
Biotech Trading Analyst @ChimeraResearch
Canada chimeraresearchgroup.com Joined December 2010
238 Following 14K Followers 41K Posts

Latest posts 5

Joe Verified account @Gantosj
25 clinical cases in just 2 weeks & multiple physicians already using the platform is exactly the kind of early adoption investors want to see.

Great start for $CNVI.V $CNVIF. The most important takeaway isn't just the1st device deployment, it's that doctors are already using & adopting #OCTIV.

"Approximately 25 clinical cases have been completed within the first two weeks of launch. Successful cases are continuing, with multiple physicians on the hospital’s team now using OCTIV."
Joe Verified account @Gantosj 2d
$CNVI.v $CNVIF Conavi Medical Announces Five-Year Extension of Credit Facilities with Japan Lifeline

Extension to April 2032 enhances financial flexibility as Conavi advances U.S. commercialization of #OCTIV™
globenewswire.com/news-release/2…
View quoted post on X
0 replies 3 reposts 9 likes 1.1K views View on X
Joe Verified account @Gantosj
$CNVI.v $CNVIF Conavi Medical Highlights Commercial Launch and Significant Growth Potential in Shareholder Letter

FDA clearance and ongoing U.S. clinical use establish a platform for OCTIV™ growth
globenewswire.com/news-release/2…
www.globenewswire.com Conavi Medical Highlights Commercial Launch and Significant Growth Potential in Shareholder Letter FDA clearance and ongoing U.S. clinical use establish a platform for OCTIV™ growth...
0 replies 2 reposts 5 likes 1.1K views View on X
Joe Verified account @Gantosj
$CNVI.v $CNVIF Conavi Medical Announces Five-Year Extension of Credit Facilities with Japan Lifeline

Extension to April 2032 enhances financial flexibility as Conavi advances U.S. commercialization of #OCTIV™
globenewswire.com/news-release/2…
www.globenewswire.com Conavi Medical Announces Five-Year Extension of Credit Facilities with Japan Lifeline Extension to April 2032 enhances financial flexibility as Conavi advances U.S. commercialization of OCTIV™...
0 replies 2 reposts 8 likes 1.9K views View on X
Joe Verified account @Gantosj
$VLTLF $LIB.V ND partner "Wellspring Hydro"

North Dakota company's years of work developing #lithium extraction opportunities from oilfield wastewater are helping pave the way for a proposed new industry that could diversify the state's energy economy and create additional value from #Bakken oil production.
ndenergy.org/Newsletter/Wra…
www.ndenergy.org Wellspring Deal to Advance Lithium Development A North Dakota company's years of work developing lithium extraction opportunities from oilfield wastewater are helping pave the way for a proposed new industry that could diversify the state's...
1 replies 5 reposts 36 likes 1.9K views View on X
Joe Verified account @Gantosj
Brookline Capital Markets maintains coverage & Buy rating for $CRDL & US$5 TP
ongoing Ph-3
MAVERIC study evaluating CardiolRx in patients with recurrent #pericarditis, with topline results expected in mid-2027

Good to watch: Investigators meeting in New York City - pericarditis health care professionals from the pivotal Ph-3 MAVERIC trial review the rational for the study & its design.
youtube.com/watch?v=9pmbEM…
www.youtube.com MAVERIC: Pivotal Phase 3 Trial in Recurrent Pericarditis Cardiol Therapeutics Inc. (CRDL), a late-stage life sciences compan...